New-onset Atrial fibrillation predicts heart failure progression

American Journal of Medicine

Volumn 127, Issue 10, 2014, Pages 963-971

  Aleong, Ryan G ^a   Sauer, William H ^a   Davis, Gordon ^b   Bristow, Michael R ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b ARCA Biopharma Inc ^*  (United States)

Author keywords

Atrial fibrillation; Beta blockers; Heart failure markers; HFrEF

Indexed keywords

BUCINDOLOL; ENALAPRIL; FUROSEMIDE; NORADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPANOLAMINE DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEW ONSET ATRIAL BRILLATION; ONSET AGE; PREDICTION; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; SURVIVAL RATE; TREATMENT OUTCOME; ATRIAL FIBRILLATION; COMPLICATION; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADRENERGIC BETA-ANTAGONISTS; AGED; ATRIAL FIBRILLATION; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPANOLAMINES; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84907971353     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.06.006     Document Type: Article

References (26)

1. C.W. Yancy, M. Jessup, and B. Bozkurt 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
2. T.M. Koelling, R.S. Chen, and R.N. Lubwama The expanding national burden of heart failure in the United States: The influence of heart failure in women Am Heart J 14 2004 74 78
3. J.B. Somaratne, C. Berry, and J.J. McMurray The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis Eur J Heart Fail 11 2009 855 862
4. I. Savelieva, and A.J. Camm Atrial fibrillation and heart failure: natural history and pharmacological treatment Europace 5 Suppl 1 2004 S5 S19
5. D.L. Packer, G.H. Bardy, and S.J. Worley Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction Am J Cardiol 57 1986 563 570
6. M. Pozzoli, G. Cioffi, and E. Traversi Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm J Am Coll Cardiol 32 1998 197 204
7. T.J. Wang, M.G. Larson, and D. Levy Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 107 2003 2920 2925
8. A.M. Chamberlain, M.M. Redfield, and A. Alonso Atrial fibrillation and mortality in heart failure: a community study Circ Heart Fail 4 2011 740 746
9. W. Zareba, J.S. Steinberg, and S. McNitt Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation Heart Rhythm 3 2006 631 637
10. D.L. Mann, and M.R. Bristow Mechanisms and models in heart failure: the biomechanical model and beyond Circulation 111 2005 2837 2849
11. M.D. Smit, M.L. Moes, and A.H. Maass The importance of whether atrial fibrillation or heart failure develops first Eur J Heart Fail 14 2012 1030 1040
12. BEST Investigators A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure N Engl J Med 344 2001 1659 1667
13. P. Carson, M. Fiuzat, and C. O'Connor Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical Trial (BEST) Am Heart J 160 2010 649 654
14. 1389 Arg/Gly adrenergic receptor polymorphism JACC Heart Fail 1 4 2013 338 344
15. D.P. Kao, G. Davis, and R. Aleong Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation Eur J Heart Fail 15 2013 324 333
16. L.Y. Chen, N. Sotoodehnia, and P. Bůžková Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study JAMA Intern Med 173 2013 29 35
17. P.M. Okin, C.N. Bang, and K. Wachtell Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy Circ Arrhythm Electrophysiol 6 2013 243 251
18. M.D. Schmiegelow, O.D. Pedersen, L. Køber, M. Seibæk, S.Z. Abildstrøm, and C. Torp-Pedersen Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study BMC Cardiovasc Disord 11 2011 19
19. M.I. Ahmed, M. White, and O.J. Ekundayo A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study Eur Heart J 30 2009 2029 2037
20. Taylor MRG, Sun AY, Davis G, Fiuzat M, Liggett SB, Bristow MR. Race, genetic variation and therapeutic response disparities in heart failure. JACC Heart Fail, in press.
21. M. Domanski, H. Krause-Steinrauf, and P. Deedwania The effect of diabetes on outcome of advanced heart failure patients in the BEST Trial J Am Coll Cardiol 42 2003 914 922
22. M.R. Bristow, H. Krause-Steinrauf, and R. Nuzzo Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial Circulation 110 11 2004 1437 1442
23. J. Seiler, and W.G. Stevenson Atrial fibrillation in congestive heart failure Cardiol Rev 18 2010 38 50
24. D.L. Dries, D.V. Exner, B.J. Gersh, M.J. Domanski, M.A. Waclawiw, and L.W. Stevenson Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials J Am Coll Cardiol 32 1998 695 703
25. O.D. Pedersen, P. Søndergaard, and T. Nielsen Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure Eur Heart J 27 2006 2866 2870
26. D.J. van Veldhuisen, H. Aass, and D. El Allaf Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study Eur J Heart Fail 8 2006 539 546